BWCS
CBIO

Beirne Wealth Consulting Services’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Beirne Wealth Consulting Services’s Portfolio CBIO Stock Details CBIO Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,000
Closed -$63K – 98
2023
Q1 		$63K Buy
50,000
+10,000
+25% +$12.6K 0.04% 96
2022
Q4 		$121K Buy
+40,000
New +$121K 0.06% 87